Search

Displaying results 5481 - 5490 of 10000 in total
  1. Pathway

    De Novo Triacylglycerol Biosynthesis TG(i-24:0/21:0/22:0)

    smpdb.ca/view/SMP0042751
    Metabolic

    (Wikipedia) De novo biosynthesis of triglycerides is also known as the phosphatidic acid pathway, and it is mainly associated with the liver and adipose tissue.

    Drugs: NADH · sn-glycerol 3-phosphate · Dihydroxyacetone phosphate
  2. Pathway

    De Novo Triacylglycerol Biosynthesis TG(i-24:0/22:0/10:0)

    smpdb.ca/view/SMP0042769
    Metabolic

    (Wikipedia) De novo biosynthesis of triglycerides is also known as the phosphatidic acid pathway, and it is mainly associated with the liver and adipose tissue.

    Drugs: NADH · sn-glycerol 3-phosphate · Dihydroxyacetone phosphate
  3. Pathway

    De Novo Triacylglycerol Biosynthesis TG(i-24:0/22:0/14:0)

    smpdb.ca/view/SMP0042772
    Metabolic

    (Wikipedia) De novo biosynthesis of triglycerides is also known as the phosphatidic acid pathway, and it is mainly associated with the liver and adipose tissue.

    Drugs: NADH · sn-glycerol 3-phosphate · Dihydroxyacetone phosphate
  4. Pathway

    De Novo Triacylglycerol Biosynthesis TG(i-24:0/22:0/16:0)

    smpdb.ca/view/SMP0042774
    Metabolic

    (Wikipedia) De novo biosynthesis of triglycerides is also known as the phosphatidic acid pathway, and it is mainly associated with the liver and adipose tissue.

    Drugs: NADH · sn-glycerol 3-phosphate · Dihydroxyacetone phosphate
  5. Pathway

    De Novo Triacylglycerol Biosynthesis TG(i-24:0/8:0/20:0)

    smpdb.ca/view/SMP0042807
    Metabolic

    (Wikipedia) De novo biosynthesis of triglycerides is also known as the phosphatidic acid pathway, and it is mainly associated with the liver and adipose tissue.

    Drugs: NADH · sn-glycerol 3-phosphate · Dihydroxyacetone phosphate
  6. Drug

    Phenylephrine

    go.drugbank.com/drugs/DB00388
    ApprovedInvestigational

    [A187370] The action of phenylephrine, or neo-synephrine, was first described in literature in the 1930s.[A187376] Phenylephrine was granted FDA approval in 1939.[L9413] … Phenylephrine is an alpha-1 adrenergic receptor agonist used to treat hypotension,[L9416,L9410] dilate the pupil,[L9413] and induce local vasoconstriction.

    Synonyms: l-(3-Hydroxyphenyl)-N-methylethanolamineMixtures: Cough-en RX Linctus, Rhume Et De LA Grippe (extra-fort)
  7. Drug

    Famotidine

    go.drugbank.com/drugs/DB00927
    ApprovedInvestigational

    It is commonly used in gastrointestinal conditions related to acid secretion, such as gastric ulcers and gastroesophageal reflux disease (GERD), in adults and children. … [A189462] Famotidine is used in various over-the-counter and off-label uses.

    Synonyms: N-Sulfamoyl-3-((2-guanidinothiazol-4-yl)methylthio)propionamide, 3-(((2-((Aminoiminomethyl)amino)-4-thiazolyl)methyl)thio)-N-(aminosulfonyl)propanimidamideMixtures: DG Health Dual Action Complete, DG Health acid reducer complete
  8. Drug

    Frovatriptan

    go.drugbank.com/drugs/DB00998
    Approved

    Frovatriptan is a triptan drug developed by Vernalis for the treatment of migraine headaches, in particular those associated with menstruation.

    Products: FROVATRIPTAN EG
  9. Drug

    Sugammadex

    go.drugbank.com/drugs/DB06206
    ApprovedInvestigational

    Sugammadex (brand name Bridion) is marketed by Merck Sharp and Dohme, and was approved by the United States FDA on December 15, 2015.

    Categories: Compounds used in a research, industrial, or household settingProducts: SUGAMMADEX DR. REDDY'S, SUGAMMADEX EG
  10. Drug

    Niacin

    go.drugbank.com/drugs/DB00627
    ApprovedInvestigationalNutraceutical

    Niacin is a B vitamin used to treat vitamin deficiencies as well as hyperlipidemia, dyslipidemia, hypertriglyceridemia, and to reduce the risk of myocardial infarctions.

    Mixtures: Ni-C-E-LE Plus, Pro Enz TabProducts: Niaspan ER